Clinical trial
Concordance Study of Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)
NCT02888717 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concordance Study of Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 28, 2015
- Completion date
- November 13, 2018
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cervical cancer